Cleared Traditional

K233791 - Drivewire 24 Guidewire (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233791 · Rapid Medical , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
226d
Days
Class 2
Risk

K233791 is an FDA 510(k) clearance for the Drivewire 24 Guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by Rapid Medical , Ltd. (Yokneam, IL). The FDA issued a Cleared decision on July 11, 2024 after a review of 226 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Rapid Medical , Ltd. devices

Submission Details

510(k) Number K233791 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2023
Decision Date July 11, 2024
Days to Decision 226 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 148d · This submission: 226d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 39
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K233791.
Aristotle 14 Guidewire
K253579 · Scientia Vascular, Inc. · Apr 2026
Zenith Micro Guidewire
K252317 · Suzhou Zenith Vascular SciTech Limited · Apr 2026
Willow 24 Guidewire
K260537 · Arbor Endovascular, LLC · Mar 2026
DCwire Micro-guidewire
K252122 · Shanghai Achieva Medical Suzhou Co., Ltd. · Mar 2026
Willow 18 Guidewire
K260130 · Arbor Endovascular, LLC · Feb 2026
CHIKAI Nexus petit
K252011 · Asahi Intecc Co., Ltd. · Feb 2026